Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 78 (1-2) , 79-92
- https://doi.org/10.1016/s0168-1702(01)00286-6
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphomaLeukemia, 2000
- A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destructionJournal of the American Academy of Dermatology, 1999
- Arsenic Trioxide and Interferon- Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I–Transformed CellsBlood, 1999
- Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell linesLeukemia Research, 1998
- Successful treatment of HTLV‐1‐associated acute adult T‐cell leukaemia lymphoma by allogeneic bone marrow transplantationBritish Journal of Haematology, 1996
- Treatment with a Combination of Zidovudine and α-Interferon in Naive and Pretreated Adult T-Cell Leukemia/Lymphoma PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Deoxycoformycin in the treatment of mature T-cell leukaemiasBritish Journal of Cancer, 1991
- A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphomaCancer, 1991
- Adult T-cell leukemia with an unusual phenotype, Leu-2a positive and Leu-3a negativeAnnals of Hematology, 1985
- Clinical Course of Retrovirus-Associated Adult T-Cell Lymphoma in the United StatesNew England Journal of Medicine, 1983